CGeneTech
CGeneTech (Suzhou, China) Co., Ltd. founded in Suzhou Industrial Park (SIP) in 2010, is dedicated to developing and commercializing innovative small molecule drugs for breakthrough therapies.
CGeneTech (Suzhou,China) Co., Ltd. is a biotechnology company in the commercialization stage, whose core product Centagliptin is about to be launched as a Class 1 innovative drug. The company was founded in Suzhou Industrial Park in 2010, with a core team boasting decades of international experience in the entire lifecycle of drugs, dedicated to the research, development and industrialization of high-quality and differentiated small-molecule innovative drugs. Leveraging its integrated drug research and development technology platform and diversified business perspectives, the company has established a rich pipeline of innovative drugs covering hypoglycemic, anticancer, and autoimmune diseases.
Dedicated to the development, manufacture and marketing of small molecule innovative drugs
Industry experience
Laboratory
Patents granted
News
Company News | Media Reports
Cooperation
We want to build long-term business relationships with customers from all over the world on a mutually beneficial basis!
Contact Us
Tel: +86-512-62956960(Recruitment)
+86-512-62956961(marketing)
E-mail:hr@cgenetech.com.cn
Copyright © 2022 CGeneTech (Suzhou, China) Co., Ltd. All rights reserved. 苏ICP备2022006552号-1 Powered by 300.cn SEO